Company Management, Scientific and Advisory Boards

Central Nervous System publications

on behalf of the Neurophenols consortium, Dal-Pan, A., Dudonné, S., Bourassa, P., Bourdoulous, M., Tremblay, C., … Calon, F. (2016). Cognitive-Enhancing Effects of a Polyphenols-Rich Extract from Fruits without Changes in Neuropathology in an Animal Model of Alzheimer’s Disease. Journal of Alzheimer’s Disease, 55(1), 115–135. https://doi.org/10.3233/JAD-160281
Belaroussi, B., Bracoud, L., Bonnand, F., Vincent, F., Noever, K., & Pachai, C. (2008). Brain atrophy measurement in multicenter studies: Application of brain boundary shift integral and jacobian integration.
Lefèvre, G., Queyrel, V., Maurage, C.-A., Laurent, C., Launay, D., Lacour, A., … Hatron, P.-Y. (2009). Effective immune restoration after immunosuppressant discontinuation in a lupus patient presenting progressive multifocal leukoencephalopathy. Journal of the Neurological Sciences, 287(1–2), 246–249. https://doi.org/10.1016/j.jns.2009.09.014
Van Laere, K., Varrone, A., Booij, J., Vander Borght, T., Nobili, F., Kapucu, Ö. L., … Darcourt, J. (2010). EANM procedure guidelines for brain neurotransmission SPECT/PET using dopamine D2 receptor ligands, version 2. European Journal of Nuclear Medicine and Molecular Imaging, 37(2), 434–442. https://doi.org/10.1007/s00259-009-1265-z
Darcourt, J., Booij, J., Tatsch, K., Varrone, A., Vander Borght, T., Kapucu, Ö. L., … Van Laere, K. (2010). EANM procedure guidelines for brain neurotransmission SPECT using 123I-labelled dopamine transporter ligands, version 2. European Journal of Nuclear Medicine and Molecular Imaging, 37(2), 443–450. https://doi.org/10.1007/s00259-009-1267-x
Bordet, R., Dartigues, J.-F., Dubois, B., Goehrs, J.-M., Vernoux, L., Semah, F., … Truffinet, P. (2010). Biomarkers for the Early Stages of Clinical Development in Alzheimer’s Disease. Therapies, 65(4), 285–290. https://doi.org/10.2515/therapie/2010040
Belaroussi, B., Bracoud, L., Noever, K., & Pachai, C. (2011). P1-295: High-throughput and accurate segmentation of lateral ventricles using combined single atlas propagation and tissue classification: Application to ADNI and IBSR data. Alzheimer’s & Dementia, 7, S204–S204. https://doi.org/10.1016/j.jalz.2011.05.574
Belaroussi, B., Bracoud, L., Noever, K., & Pachai, C. (2011). P1-294: Whole-brain and ventricular volume change measurement in multicenter clinical trials: A feasibility study of Jacobian Integration using ADNI data. Alzheimer’s & Dementia, 7, S204–S204. https://doi.org/10.1016/j.jalz.2011.05.573
Rolland, Y., Verin, M., Payan, C. A., Duchesne, S., Kraft, E., Hauser, T. K., … on behalf of the NNIPPS Study Group. (2011). A new MRI rating scale for progressive supranuclear palsy and multiple system atrophy: validity and reliability. Journal of Neurology, Neurosurgery & Psychiatry, 82(9), 1025–1032. https://doi.org/10.1136/jnnp.2010.214890
Lenfant, P., Ravasi, L., Petyt, G., Lebouc, R., Henry, S., Pallardy, A., … Lejeune, F. (2011). Apport de deux techniques d’analyse automatisées des examens [18F] FDG TEP dans la discrimination des patients déments frontotemporaux et malades d’Alzheimer. Médecine Nucléaire, 35(3), 136–145. https://doi.org/10.1016/j.mednuc.2011.01.005
de Margerie-Mellon, C., Turc, G., Tisserand, M., Naggara, O., Calvet, D., Legrand, L., … Oppenheim, C. (2013). Can DWI-ASPECTS Substitute for Lesion Volume in Acute Stroke? Stroke, 44(12), 3565–3567. https://doi.org/10.1161/STROKEAHA.113.003047
Petyt, G., Kreisler, A., Demailly, F., Olivier, A., Defebvre, L., & Semah, F. (2014). Undetectable specific striatal [123I]-ioflupane binding in patients with parkinsonism. Journal of the Neurological Sciences, 341(1–2), 167–171. https://doi.org/10.1016/j.jns.2014.04.024
Darcourt, J., Schiazza, A., Sapin, N., Dufour, M., Ouvrier, M. J., Benisvy, D., … Koulibaly, P. M. (2014). 18F-FDOPA PET for the diagnosis of parkinsonian syndromes. The Quarterly Journal of Nuclear Medicine and Molecular Imaging: Official Publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society Of..., 58(4), 355–365.
Semah, F., Thomas, P., Coulbaut, S., & Derambure, P. (2014). Early add-on treatment vs alternative monotherapy in patients with partial epilepsy. Epileptic Disorders, 16(2), 165–174. https://doi.org/10.1684/epd.2014.0650
Tard, C., Demailly, F., Delval, A., Semah, F., Defebvre, L., Dujardin, K., & Moreau, C. (2015). Hypometabolism in Posterior and Temporal Areas of the Brain is Associated with Cognitive Decline in Parkinson’s Disease. Journal of Parkinson’s Disease, 5(3), 569–574. https://doi.org/10.3233/JPD-150583
Salabert, A.-S., Fonta, C., Fontan, C., Adel, D., Alonso, M., Pestourie, C., … Payoux, P. (2015). Radiolabeling of [18F]-fluoroethylnormemantine and initial in vivo evaluation of this innovative PET tracer for imaging the PCP sites of NMDA receptors. Nuclear Medicine and Biology, 42(8), 643–653. https://doi.org/10.1016/j.nucmedbio.2015.04.001
Didic, M., Felician, O., Gour, N., Bernard, R., Pécheux, C., Mundler, O., … Guedj, E. (2015). Rhinal hypometabolism on FDG PET in healthy APO-E4 carriers: impact on memory function and metabolic networks. European Journal of Nuclear Medicine and Molecular Imaging, 42(10), 1512–1521. https://doi.org/10.1007/s00259-015-3057-y
Collart Dutilleul, P., Ryvlin, P., Kahane, P., Vercueil, L., Semah, F., Biraben, A., … Collongues, N. (2016). Exploratory Phase II Trial to Evaluate the Safety and the Antiepileptic Effect of Pitolisant (BF2.649) in Refractory Partial Seizures, Given as Adjunctive Treatment During 3 Months: Clinical Neuropharmacology, 39(4), 188–193. https://doi.org/10.1097/WNF.0000000000000159
Chassoux, F., Artiges, E., Semah, F., Desarnaud, S., Laurent, A., Landre, E., … Helal, O. B. (2016). Determinants of brain metabolism changes in mesial temporal lobe epilepsy. Epilepsia, 57(6), 907–919. https://doi.org/10.1111/epi.13377
Verclytte, S., Lopes, R., Lenfant, P., Rollin, A., Semah, F., Leclerc, X., … Delmaire, C. (2016). Cerebral Hypoperfusion and Hypometabolism Detected by Arterial Spin Labeling MRI and FDG-PET in Early-Onset Alzheimer’s Disease: ASL and FDG-PET Patterns Associated with EOAD. Journal of Neuroimaging, 26(2), 207–212. https://doi.org/10.1111/jon.12264
Semah, F., Deberdt, W., & Ceccaldi, M. (2016). Diagnostic de la maladie d’Alzheimer : apport de l’imagerie au florbétapir et autres radiopharmaceutiques de la plaque amyloïde. Médecine Nucléaire, 40(5), 364–381. https://doi.org/10.1016/j.mednuc.2016.08.001
Koric, L., Guedj, E., Habert, M. O., Semah, F., Branger, P., Payoux, P., & Le Jeune, F. (2016). Molecular imaging in the diagnosis of Alzheimer’s disease and related disorders. Revue Neurologique, 172(12), 725–734. https://doi.org/10.1016/j.neurol.2016.10.009
Joubert, S., Gour, N., Guedj, E., Didic, M., Guériot, C., Koric, L., … Ceccaldi, M. (2016). Early-onset and late-onset Alzheimer’s disease are associated with distinct patterns of memory impairment. Cortex, 74, 217–232. https://doi.org/10.1016/j.cortex.2015.10.014
Salabert, A.-S., Mora-Ramirez, E., Beaurain, M., Alonso, M., Fontan, C., Tahar, H. B., … Payoux, P. (2018). Evaluation of [ 18 F]FNM biodistribution and dosimetry based on whole-body PET imaging of rats. Nuclear Medicine and Biology, 59, 1–8. https://doi.org/10.1016/j.nucmedbio.2017.12.003
Payoux, P., & Salabert, A. S. (2017). New PET markers for the diagnosis of dementia: Current Opinion in Neurology, 30(6), 608–616. https://doi.org/10.1097/WCO.0000000000000489
Chassoux, F., Artiges, E., Semah, F., Laurent, A., Landré, E., Turak, B., … Devaux, B. (2017). 18 F-FDG-PET patterns of surgical success and failure in mesial temporal lobe epilepsy. Neurology, 88(11), 1045–1053. https://doi.org/10.1212/WNL.0000000000003714
Vanhoutte, M., Semah, F., Rollin Sillaire, A., Jaillard, A., Petyt, G., Kuchcinski, G., … Lopes, R. (2017). 18F-FDG PET hypometabolism patterns reflect clinical heterogeneity in sporadic forms of early-onset Alzheimer’s disease. Neurobiology of Aging, 59, 184–196. https://doi.org/10.1016/j.neurobiolaging.2017.08.009
Van Der Gucht, A., Aoun Sebaiti, M., Guedj, E., Aouizerate, J., Yara, S., Gherardi, R. K., … Authier, F.-J. (2017). Brain 18 F-FDG PET Metabolic Abnormalities in Patients with Long-Lasting Macrophagic Myofascitis. Journal of Nuclear Medicine, 58(3), 492–498. https://doi.org/10.2967/jnumed.114.151878
Aziz, A.-L., Giusiano, B., Joubert, S., Duprat, L., Didic, M., Gueriot, C., … Ceccaldi, M. (2017). Difference in imaging biomarkers of neurodegeneration between early and late-onset amnestic Alzheimer’s disease. Neurobiology of Aging, 54, 22–30. https://doi.org/10.1016/j.neurobiolaging.2017.02.010
Desarnaud, S., Mellerio, C., Semah, F., Laurent, A., Landre, E., Devaux, B., … Chassoux, F. (2018). Correction to: 18F-FDG PET in drug-resistant epilepsy due to focal cortical dysplasia type 2: additional value of electroclinical data and coregistration with MRI. European Journal of Nuclear Medicine and Molecular Imaging, 45(8), 1465–1465. https://doi.org/10.1007/s00259-018-4022-3
Desarnaud, S., Mellerio, C., Semah, F., Laurent, A., Landre, E., Devaux, B., … Chassoux, F. (2018). 18F-FDG PET in drug-resistant epilepsy due to focal cortical dysplasia type 2: additional value of electroclinical data and coregistration with MRI. European Journal of Nuclear Medicine and Molecular Imaging, 45(8), 1449–1460. https://doi.org/10.1007/s00259-018-3994-3
Ceccaldi, M., Jonveaux, T., Verger, A., Krolak-Salmon, P., Houzard, C., Godefroy, O., … Guedj, E. (2018). Added value of 18 F-florbetaben amyloid PET in the diagnostic workup of most complex patients with dementia in France: A naturalistic study. Alzheimer’s & Dementia, 14(3), 293–305. https://doi.org/10.1016/j.jalz.2017.09.009
Ben Bouallègue, F., Vauchot, F., Mariano-Goulart, D., & Payoux, P. (2019). Diagnostic and prognostic value of amyloid PET textural and shape features: comparison with classical semi-quantitative rating in 760 patients from the ADNI-2 database. Brain Imaging and Behavior, 13(1), 111–125. https://doi.org/10.1007/s11682-018-9833-0
for the Alzheimer’s Disease Neuroimaging Initiative (ADNI), Ben Bouallègue, F., Mariano-Goulart, D., & Payoux, P. (2018). Joint Assessment of Quantitative 18F-Florbetapir and 18F-FDG Regional Uptake Using Baseline Data from the ADNI. Journal of Alzheimer’s Disease, 62(1), 399–408. https://doi.org/10.3233/JAD-170833